These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17453372)

  • 21. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Ma J; Chen LH; Xia YF; Shi YS
    Radiother Oncol; 2005 May; 75(2):197-203. PubMed ID: 15876464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
    Xiance J; Shixiu W; Jianyi Y; Jinling Y
    Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
    Chung HT; Lee B; Park E; Lu JJ; Xia P
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1167-74. PubMed ID: 18234440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus.
    Fenkell L; Kaminsky I; Breen S; Huang S; Van Prooijen M; Ringash J
    Radiother Oncol; 2008 Dec; 89(3):287-91. PubMed ID: 18789828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D-Conformal versus intensity-modulated postoperative radiotherapy of vaginal vault: A dosimetric comparison.
    Cilla S; Macchia G; Digesù C; Deodato F; Romanella M; Ferrandina G; Padula GD; Picardi V; Scambia G; Piermattei A; Morganti AG
    Med Dosim; 2010; 35(2):135-42. PubMed ID: 19931026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.
    Teo PM; Ma BB; Chan AT
    Radiother Oncol; 2004 Nov; 73(2):163-72. PubMed ID: 15542163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
    Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
    Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Three-dimensional conformal radiotherapy for primary nasopharyngeal carcinoma and analysis of locoregional recurrence].
    Tang YQ; Luo W; He ZC; Sun Y; Lu TX
    Ai Zheng; 2006 Mar; 25(3):330-4. PubMed ID: 16536988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience.
    Bišof V; Rakušić Z; Bibić J; Grego T; Soče M
    Radiol Med; 2018 Mar; 123(3):217-226. PubMed ID: 29094268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques.
    Rusthoven KE; Carter DL; Howell K; Kercher JM; Henkenberns P; Hunter KL; Leonard CE
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):296-302. PubMed ID: 18086392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of multileaf collimators leaf width on intensity-modulated radiotherapy planning for nasopharyngeal carcinoma: analysis of two commercial elekta devices.
    Wang S; Gong Y; Xu Q; Bai S; Lu Y; Jiang Q; Chen N
    Med Dosim; 2011; 36(2):153-9. PubMed ID: 20488691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
    Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignancies.
    Ahmed RS; De Los Santos JF; Fiveash JB; Keene KS; Popple RA
    Med Dosim; 2008; 33(1):71-7. PubMed ID: 18262126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation.
    Ahunbay EE; Chen GP; Thatcher S; Jursinic PA; White J; Albano K; Li XA
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1248-58. PubMed ID: 17275205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Chua DT; Sham JS; Leung LH; Au GK
    Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J; Kim RY; Elassal S; Lin HY; Shen S
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.